Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$489,523,063
+$32,730,209 QoQ
Shares Held
3,809,518
+0.3% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#67
of 3,757 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $4,800,494,597 across 17 Drug Manufacturers - General names. MRK ranks #4 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,333,307 | $1,599,208,548 | |
| 2 | JNJ |
Johnson & Johnson
|
3,780,752 | $960,197,585 | |
| 3 | ABBV |
AbbVie Inc.
|
2,733,648 | $687,895,182 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
3,809,518 | $489,523,063 | |
| 5 | AMGN |
Amgen Inc
|
904,954 | $327,701,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,051,819 | $259,226,812 | |
| 7 | PFE |
Pfizer Inc
|
8,609,603 | $207,319,240 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,347,347 | $192,874,134 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $489,523,063 | 3,809,518 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $456,792,854 | 3,797,430 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $418,542,074 | 3,976,269 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $344,143,046 | 4,100,358 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $325,284,905 | 4,109,208 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $403,290,154 | 4,492,983 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $444,011,073 | 4,463,320 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $512,989,698 | 4,517,345 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $565,349,413 | 4,566,635 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $587,066,925 | 4,449,162 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $496,829,541 | 4,557,233 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $472,032,441 | 4,585,065 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $529,183,847 | 4,586,046 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $479,107,257 | 4,503,311 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $486,774,596 | 4,387,333 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $364,429,698 | 4,231,650 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $371,782,690 | 4,077,906 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $320,730,332 | 3,908,962 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $284,862,449 | 3,716,890 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $276,500,039 | 3,681,268 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $302,168,957 | 3,885,418 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $313,952,817 | 4,072,547 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $343,844,100 | 4,203,475 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $367,392,936 | 4,429,087 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $342,758,955 | 4,432,417 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $319,369,189 | 4,150,888 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||